224 related articles for article (PubMed ID: 27397923)
1. Effects of sublingual immunotherapy in a murine asthma model sensitized by intranasal administration of house dust mite extracts.
Shima K; Koya T; Tsukioka K; Sakagami T; Hasegawa T; Fukano C; Ohashi-Doi K; Watanabe S; Suzuki E; Kikuchi T
Allergol Int; 2017 Jan; 66(1):89-96. PubMed ID: 27397923
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
3. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
4. Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model.
Verheijden KA; Willemsen LE; Braber S; Leusink-Muis T; Delsing DJ; Garssen J; Kraneveld AD; Folkerts G
Respir Res; 2015 Feb; 16(1):17. PubMed ID: 25849971
[TBL] [Abstract][Full Text] [Related]
5. House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma.
Hagner S; Rask C; Brimnes J; Andersen PS; Raifer H; Renz H; Garn H
Int Arch Allergy Immunol; 2016; 170(1):22-34. PubMed ID: 27287860
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation.
Tourdot S; Airouche S; Berjont N; Da Silveira A; Mascarell L; Jacquet A; Caplier L; Langelot M; Baron-Bodo V; Moingeon P
Clin Exp Allergy; 2011 Dec; 41(12):1784-92. PubMed ID: 22092967
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of Galectin-9 on allergen-specific sublingual immunotherapy in a Dermatophagoides farinae-induced mouse model of chronic asthma.
Ikeda M; Katoh S; Shimizu H; Hasegawa A; Ohashi-Doi K; Oka M
Allergol Int; 2017 Jul; 66(3):432-439. PubMed ID: 27876361
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of transdermal immunotherapy with biodegradable microneedle patches in a murine asthma model.
Park KH; Oh EY; Han H; Kim JD; Kim SJ; Jeong KY; Kim JH; Park CO; Kim SR; Lee JH; Jeong DH; Yong TS; Lee KH; Park JW
Clin Exp Allergy; 2020 Sep; 50(9):1084-1092. PubMed ID: 32557846
[TBL] [Abstract][Full Text] [Related]
12. Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
Yang J; Ramirez Moral I; van 't Veer C; de Vos AF; de Beer R; Roelofs JJTH; Morgan BP; van der Poll T
Respir Res; 2019 Jul; 20(1):165. PubMed ID: 31340811
[TBL] [Abstract][Full Text] [Related]
13. Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis.
Jordakieva G; Kundi M; Lemell P; Zieglmayer R; Zieglmayer P; Godnic-Cvar J; Jensen-Jarolim E
Sci Rep; 2017 May; 7(1):2555. PubMed ID: 28566688
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
16. A single injection of a sustained-release prostacyclin analog (ONO-1301MS) suppresses airway inflammation and remodeling in a chronic house dust mite-induced asthma model.
Kimura Y; Koya T; Kagamu H; Shima K; Sakamoto H; Kawakami H; Hoshino Y; Furukawa T; Sakagami T; Hasegawa T; Narita M; Suzuki E; Narita I
Eur J Pharmacol; 2013 Dec; 721(1-3):80-5. PubMed ID: 24128591
[TBL] [Abstract][Full Text] [Related]
17. The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V.
Verheijden KA; Willemsen LE; Braber S; Leusink-Muis T; Jeurink PV; Garssen J; Kraneveld AD; Folkerts G
Eur J Nutr; 2016 Apr; 55(3):1141-51. PubMed ID: 26003185
[TBL] [Abstract][Full Text] [Related]
18. Bronchom assuages airway hyperresponsiveness in house dust mite-induced mouse model of allergic asthma and moderates goblet cell metaplasia, sub-epithelial fibrosis along with changes in Th2 cytokines and chemokines.
Balkrishna A; Sinha S; Karumuri S; Maity M; Dev R; Varshney A
Front Immunol; 2024; 15():1384697. PubMed ID: 38807596
[TBL] [Abstract][Full Text] [Related]
19. CD44 is critical for the enhancing effect of hyaluronan in allergen-specific sublingual immunotherapy in a murine model of chronic asthma.
Katoh S; Uesaka T; Tanaka H; Matsuhara H; Ohashi-Doi K; Oga T
Clin Exp Immunol; 2022 Jun; 208(2):202-211. PubMed ID: 35429379
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice.
Ma WJ; Bao MJ; Zhu JP; Yao HY; Xie YC; Guan Y; Li FF; Dong XW; Zheng YM; Xie QM
Vaccine; 2012 Feb; 30(8):1437-44. PubMed ID: 22240342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
